Global Scans · Genetics · Weekly Summary

• [New] Just this month, for instance, researchers in Chile found evidence in mice that sucralose and stevia can potentially alter the gut microbiome and affect genes linked to metabolism and inflammation in negative ways-changes that could even be passed on to later generations. Gizmodo
• [New] The study in JAMA Network Open found prediabetic adults with certain variations in the vitamin D receptor gene had a 19% lower risk of developing diabetes when taking a high daily dose of vitamin D. Futurity
• [New] HHS, the FDA, and the US Department of Veterans Affairs will collaborate with one another - and where appropriate, the private sector - to increase clinical trial participation, expand data sharing, and generate real-world evidence. ArentFox Schiff
• [New] By 2035, the role of GLP-1 RAs as potential lifelong treatment will become clearer, with generic market expansion anticipated following patent expirations (China 2026; Europe 2031). PubMed Central (PMC)
• [New] As generics expand access and ongoing research clarifies long-term outcomes, healthcare systems will adapt to prioritise obesity treatment, ultimately improving population health and quality of life worldwide. PubMed Central (PMC)
• [New] Generic formulations - particularly from Indian, Chinese and Brazilian manufacturers - are expected to expand access significantly following patent expirations between 2026 and 2031 [36. PubMed Central (PMC)
• [New] A treatment made by Regeneron Pharmaceuticals could be the first gene therapy for deafness to earn approval from the FDA. Live Science
• [New] European startups like Wayve lead development of next-generation AI models that could leapfrog current technological approaches. Natixis - Natixis CIB
• [New] Surveyed healthcare leaders most often cite administrative efficiency as the domain with the greatest potential for both generative AI and multiagent workflows. Daily AI Mail
• [New] Gartner's top Data & Analytics predictions for 2026 highlight that AI agents are expected to generate ten times more data from physical environments than from all digital AI applications combined by 2029 - making robust analytics infrastructure not a luxury, but a baseline requirement. Tech Funding News
• [New] Generative AI could generate $4.4 trillion in annual economic value globally. TechStoriess.com
• [New] Generative AI alone could contribute $4.4 trillion to the global economy annually. TechStoriess.com
• [New] Over 50% of enterprise generative AI models will be purpose-built for specific domains in the coming years. TechStoriess.com
• [New] OpenAI announced that it will discontinue Sora and withdraw from the video-generation market, reallocating resources toward more profitable verticals such as enterprise products, coding assistants, and long-horizon research. AI Agents Simplified
• [New] The Generative AI market reached $257.5 million in 2025 and is projected to hit $1.035 billion by 2034, growing at 16.22% CAGR. Alcor Recruitment & EOR for Tech
• [New] Enterprise generative AI spending reached $15 B in 2023 (about 2% of the global enterprise software market) and projects the gen AI software category will hit $175 B to $250 B by 2027. Preuve AI
• [New] Broader generative AI software spending could reach $175 B to $250 B by 2027, with software engineering alone accounting for 20-45% of generative AI's total annual economic value. Preuve AI
• While the practice of whole genomic sequencing could be a key technology leveraged by NICUs and PICUs to assist in making treatment decisions of acutely-ill babies, a pediatric genomic medicine knowledge gap currently exists between many healthcare providers in the United States. Frontiers 26
• A new regulatory framework proposed in February by the US Food and Drug Administration could dramatically reduce the time and cost of bringing personalised CRISPR-Cas gene-editing therapies to patients with rare genetic diseases. CRISPR Medicine
• New Australian research has highlighted the urgent need for a national framework to guide genetic testing for prostate cancer, with experts warning that current policy settings are leaving many men and their families without access to potentially life-saving information. PCFA
• Portable genetic sequencers used around the world to sequence DNA have critical, previously unreported security vulnerabilities that could reveal or alter genetic information without detection. EurekAlert!
• Advances in synthetic biology & fusion energy will influence global sustainability efforts, while next-generation materials will enable lighter, stronger & more efficient technologies. UnfoldLabs
• CFS plans to move immediately into construction of its first commercial plant in Virginia once SPARC starts, positioning the 400 megawatt site as the world's first commercial plant to generate power with fusion. The Fusion Report: The Business of Fusion Energy

Last updated: 03 May 2026